T
T Man Pharmaceutical PCL
SET:TMAN
T Man Pharmaceutical PCL
SET:TMAN
Price:
12.9
THB
Market Cap:
฿5.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
TH |
|
CeCors Inc
OTC:CEOS
|
CA |
|
E
|
Enersense International Oyj
OMXH:ESENSE
|
FI |
|
M
|
Mount Burgess Mining NL
ASX:MTB
|
AU |
|
N
|
N K Industries Ltd
NSE:NKIND
|
IN |
|
Ostin Technology Group Co Ltd
NASDAQ:OST
|
CN |
|
Jiamei Food Packaging Chuzhou Co Ltd
SZSE:002969
|
CN |
|
J
|
Jet.AI Inc
NASDAQ:JTAI
|
US |
|
R
|
Rugvista Group AB (publ)
STO:RUG
|
SE |
|
shipping corporation of India Ltd
NSE:SCI
|
IN |
|
Nicco Parks & Resorts Ltd
BSE:526721
|
IN |
|
Nedap NV
LSE:0NNU
|
NL |
|
Zhejiang Mustang Battery Co Ltd
SSE:605378
|
CN |
|
F
|
Farmae SpA
MIL:FAR
|
IT |
|
A
|
ANI Joint Stocks Co
VN:SIC
|
VN |
|
C
|
Cochlear Ltd
OTC:CHEOF
|
AU |
|
C
|
Catalyst Bancorp Inc
NASDAQ:CLST
|
US |
|
A
|
Akfen Yenilenebilir Enerji AS
IST:AKFYE.E
|
TR |
|
Panex Resources Inc
OTC:DBGF
|
MC |
|
P
|
Paninvest Tbk PT
XBER:OA9
|
ID |
|
B
|
B2Gold Corp
AMEX:BTG
|
CA |
|
P
|
Provident Financial Holdings Inc
NASDAQ:PROV
|
US |
Balance Sheet
Balance Sheet Decomposition
T Man Pharmaceutical PCL
T Man Pharmaceutical PCL
Balance Sheet Decomposition is not available for
T Man Pharmaceutical PCL
T Man Pharmaceutical PCL
Balance Sheet
T Man Pharmaceutical PCL
T Man Pharmaceutical PCL
Currency: THB
| Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
307
|
348
|
348
|
399
|
|
| Cash |
307
|
348
|
108
|
396
|
|
| Cash Equivalents |
0
|
0
|
241
|
3
|
|
| Short-Term Investments |
0
|
0
|
450
|
352
|
|
| Total Receivables |
529
|
617
|
617
|
1 038
|
|
| Accounts Receivables |
507
|
578
|
596
|
848
|
|
| Other Receivables |
21
|
39
|
21
|
190
|
|
| Inventory |
358
|
482
|
541
|
613
|
|
| Other Current Assets |
32
|
5
|
4
|
3
|
|
| Total Current Assets |
1 226
|
1 451
|
1 960
|
2 406
|
|
| PP&E Net |
930
|
1 048
|
1 143
|
1 204
|
|
| PP&E Gross |
930
|
1 048
|
1 143
|
1 204
|
|
| Accumulated Depreciation |
603
|
691
|
776
|
768
|
|
| Intangible Assets |
13
|
26
|
34
|
45
|
|
| Long-Term Investments |
42
|
41
|
241
|
40
|
|
| Other Long-Term Assets |
67
|
61
|
77
|
89
|
|
| Total Assets |
2 278
N/A
|
2 627
+15%
|
3 456
+32%
|
3 784
+9%
|
|
| Liabilities | |||||
| Accounts Payable |
333
|
332
|
381
|
508
|
|
| Short-Term Debt |
122
|
151
|
1 080
|
875
|
|
| Current Portion of Long-Term Debt |
27
|
40
|
6
|
5
|
|
| Other Current Liabilities |
617
|
499
|
110
|
166
|
|
| Total Current Liabilities |
1 099
|
1 022
|
1 576
|
1 553
|
|
| Long-Term Debt |
77
|
48
|
65
|
63
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
|
| Other Liabilities |
59
|
38
|
45
|
50
|
|
| Total Liabilities |
1 236
N/A
|
1 108
-10%
|
1 686
+52%
|
1 667
-1%
|
|
| Equity | |||||
| Common Stock |
187
|
246
|
300
|
300
|
|
| Retained Earnings |
549
|
967
|
76
|
423
|
|
| Additional Paid In Capital |
306
|
306
|
1 394
|
1 394
|
|
| Total Equity |
1 042
N/A
|
1 519
+46%
|
1 770
+16%
|
2 117
+20%
|
|
| Total Liabilities & Equity |
2 278
N/A
|
2 627
+15%
|
3 456
+32%
|
3 784
+9%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
400
|
400
|
400
|
400
|
|
Switch to:
Switch to:
See Also
Discover More
